Category:

Vertex Sets CEO Succession as David DeStefano Announces Retirement

Vertex has appointed Christopher Young as its new President and CEO, adding him to the Board as part of the transition. His appointment follows an external search run with an independent firm and marks the succession of David DeStefano, who retired after 26 years. Young joins the company with a long track record in major technology organizations, including leadership roles at Microsoft, McAfee, Cisco, Intel, and VMware…

Posted On :
Category:

Simplifying Diabetes Management: Glooko’s Mike Alvarez

In this episode, we speak with Mike Alvarez, CEO and President of Glooko, a digital health company that connects people with diabetes to their care teams through a unified data platform. By syncing with more than 200 devices and integrating directly into electronic health records, Glooko simplifies data management, enables remote patient monitoring, and strengthens collaboration between patients, providers, and caregivers. Today, the platform supports over 4.4 million users in 30 countries…

Posted On :
Category:

Recursion Outlines CEO Transition for Next Growth Stage in January 2026

Recursion, a clinical-stage TechBio company focused on advancing data-driven drug discovery, has approved a leadership transition that will take effect on January 1, 2026. The Board selected Najat Khan, PhD, currently Chief R&D and Commercial Officer and a director, to succeed Co-Founder and CEO Chris Gibson, PhD, who will become Chairman and serve as an interim Executive Advisor…

Posted On :